Fighting cancer: Dr Chow, who led the NUS team, hopes to start in-human clinical trials in about two years. — The Straits Times / Asia News Network
A STUDY led by the National University of Singapore (NUS) has found a way to use chemotherapy to shrink cancerous tumours while also minimising relapses and harmful side effects.
The team has managed to make a common chemotherapy drug, epirubicin, more effective in targeting cancer stem cells, which cause tumours to grow.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
